NCT01134120 2018-04-17A Study in Myeloproliferative DisordersEli Lilly and CompanyPhase 1 Completed80 enrolled
NCT01520220 2017-04-12Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsEli Lilly and CompanyPhase 1 Completed100 enrolled